# SurgePays, Inc.: financial statements, quarterly

SURG · Nasdaq · CIK 1392694 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/surg.md) · [Financials](/companies/surg/financials.md) · [Filings](/companies/surg/filings.md) · [Insiders](/companies/surg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/surg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.2](/filings/0001493152-24-044766.md) | [32.3 d](/filings/0001641172-25-000608.md) | [31.4](/filings/0001641172-25-009972.md) | [15.1](/filings/0001641172-25-023493.md) | [4.8](/filings/0001493152-25-021950.md) | [9.6 d](/filings/0001493152-26-016889.md) | [10.6](/filings/0001493152-26-024591.md) | [11.5](/filings/0001493152-26-039250.md) | [18.7](/filings/0001493152-25-021950.md) | [16.2 d](/filings/0001493152-26-016889.md) | [16.0](/filings/0001493152-26-024591.md) | [16.2](/filings/0001493152-26-039250.md) |
| Cost of revenue | $m | [23.7](/filings/0001493152-24-044766.md) | [24.9 d](/filings/0001641172-25-000608.md) | [23.2](/filings/0001641172-25-009972.md) | [18.5](/filings/0001641172-25-023493.md) | [12.6](/filings/0001493152-25-021950.md) | [20.8 d](/filings/0001493152-26-016889.md) | [13.5](/filings/0001493152-26-024591.md) | [14.2](/filings/0001493152-26-039250.md) | [21.3](/filings/0001493152-25-021950.md) | [18.6 d](/filings/0001493152-26-016889.md) | [23.7](/filings/0001493152-26-024591.md) | [16.6](/filings/0001493152-26-039250.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [3.4](/filings/0001493152-24-044766.md) | [6.6 d](/filings/0001641172-25-000608.md) | [6.4](/filings/0001641172-25-009972.md) | [7.4](/filings/0001641172-25-023493.md) | [6.4](/filings/0001493152-25-021950.md) | [7.1 d](/filings/0001493152-26-016889.md) | [4.6](/filings/0001493152-26-024591.md) | [4.2](/filings/0001493152-26-039250.md) | [4.4](/filings/0001493152-25-021950.md) | [6.9 d](/filings/0001493152-26-016889.md) | [3.5](/filings/0001493152-26-024591.md) | [4.6](/filings/0001493152-26-039250.md) |
| Operating income | $m | [7.1](/filings/0001493152-24-044766.md) | [0.9 d](/filings/0001641172-25-000608.md) | [1.8](/filings/0001641172-25-009972.md) | [(10.9)](/filings/0001641172-25-023493.md) | [(14.3)](/filings/0001493152-25-021950.md) | [(20.1) d](/filings/0001493152-26-016889.md) | [(7.6)](/filings/0001493152-26-024591.md) | [(6.8)](/filings/0001493152-26-039250.md) | [(7.0)](/filings/0001493152-25-021950.md) | [(12.8) d](/filings/0001493152-26-016889.md) | [(11.2)](/filings/0001493152-26-024591.md) | [3.5](/filings/0001493152-26-039250.md) |
| Interest expense | $m | not reported | not reported | not reported | [0.1](/filings/0001641172-25-023493.md) | [0.1](/filings/0001493152-25-021950.md) | [0.2 d](/filings/0001493152-26-016889.md) | [0.1](/filings/0001493152-26-024591.md) | [0.3](/filings/0001493152-26-039250.md) | [0.4](/filings/0001493152-25-021950.md) | [1.2 d](/filings/0001493152-26-016889.md) | [0.9](/filings/0001493152-26-024591.md) | [1.0](/filings/0001493152-26-039250.md) |
| Income tax | $m | not reported | not reported | [0.4](/filings/0001641172-25-009972.md) | [2.5](/filings/0001641172-25-023493.md) | [0.0 d](/filings/0001493152-25-021950.md) | [(0.1) d](/filings/0001493152-26-016889.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [7.1](/filings/0001493152-24-044766.md) | [3.0 d](/filings/0001641172-25-000608.md) | [1.2](/filings/0001493152-25-021950.md) | [(12.9)](/filings/0001493152-25-021950.md) | [(14.3)](/filings/0001493152-25-021950.md) | [(19.8) d](/filings/0001493152-26-016889.md) | [(7.6)](/filings/0001493152-26-039250.md) | [(7.1)](/filings/0001493152-26-039250.md) | [(7.5)](/filings/0001493152-25-021950.md) | [(13.9) d](/filings/0001493152-26-016889.md) | [(12.1)](/filings/0001493152-26-039250.md) | [1.3](/filings/0001493152-26-039250.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001493152-24-044766.md) | not reported | [0.07](/filings/0001641172-25-009972.md) | [(0.66)](/filings/0001641172-25-023493.md) | [(0.73)](/filings/0001493152-25-021950.md) | not reported | [(0.38)](/filings/0001493152-26-024591.md) | [(0.36)](/filings/0001493152-26-039250.md) | [(0.38)](/filings/0001493152-25-021950.md) | not reported | [(0.51)](/filings/0001493152-26-024591.md) | [0.05](/filings/0001493152-26-039250.md) |
| Basic EPS | $ per share | [0.50](/filings/0001493152-24-044766.md) | not reported | [0.07](/filings/0001641172-25-009972.md) | [(0.66)](/filings/0001641172-25-023493.md) | [(0.73)](/filings/0001493152-25-021950.md) | not reported | [(0.38)](/filings/0001493152-26-024591.md) | [(0.36)](/filings/0001493152-26-039250.md) | [(0.38)](/filings/0001493152-25-021950.md) | not reported | [(0.51)](/filings/0001493152-26-024591.md) | [0.05](/filings/0001493152-26-039250.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.7](/filings/0001493152-23-041181.md) | [14.6](/filings/0001641172-25-000608.md) | [42.9](/filings/0001493152-24-018890.md) | [38.4](/filings/0001493152-24-031624.md) | [13.7](/filings/0001493152-24-044766.md) | [11.8](/filings/0001493152-26-016889.md) | [5.4](/filings/0001641172-25-009972.md) | [4.4](/filings/0001493152-26-039250.md) | [2.5](/filings/0001493152-25-021950.md) | [1.7](/filings/0001493152-26-039250.md) | [2.0](/filings/0001493152-26-024591.md) | [2.0](/filings/0001493152-26-039250.md) |
| Current assets | $m | [37.3](/filings/0001493152-23-041181.md) | [33.4](/filings/0001641172-25-000608.md) | [59.1](/filings/0001493152-24-018890.md) | [48.7](/filings/0001493152-24-031624.md) | [33.9](/filings/0001493152-24-044766.md) | [17.9](/filings/0001493152-26-016889.md) | [9.9](/filings/0001641172-25-009972.md) | [9.7](/filings/0001641172-25-023493.md) | [9.2](/filings/0001493152-25-021950.md) | [7.0](/filings/0001493152-26-039250.md) | [8.2](/filings/0001493152-26-024591.md) | [4.9](/filings/0001493152-26-039250.md) |
| Total assets | $m | [43.2](/filings/0001493152-23-041181.md) | [41.9](/filings/0001641172-25-000608.md) | [69.6](/filings/0001493152-24-018890.md) | [56.4](/filings/0001493152-24-031624.md) | [41.5](/filings/0001493152-24-044766.md) | [24.0](/filings/0001493152-26-016889.md) | [15.7](/filings/0001641172-25-009972.md) | [15.2](/filings/0001641172-25-023493.md) | [14.5](/filings/0001493152-25-021950.md) | [8.5](/filings/0001493152-26-039250.md) | [9.5](/filings/0001493152-26-024591.md) | [9.2](/filings/0001493152-26-039250.md) |
| Current liabilities | $m | [14.5](/filings/0001493152-23-041181.md) | [12.7](/filings/0001641172-25-000608.md) | [9.4](/filings/0001493152-24-018890.md) | [6.6](/filings/0001493152-24-031624.md) | [5.4](/filings/0001493152-24-044766.md) | [6.1](/filings/0001493152-26-016889.md) | [5.7](/filings/0001641172-25-009972.md) | [8.7](/filings/0001641172-25-023493.md) | [17.7](/filings/0001493152-25-021950.md) | [18.2](/filings/0001493152-26-039250.md) | [30.0](/filings/0001493152-26-024591.md) | [26.2](/filings/0001493152-26-039250.md) |
| Total liabilities | $m | [19.4](/filings/0001493152-23-041181.md) | [13.5](/filings/0001641172-25-000608.md) | [13.4](/filings/0001493152-24-018890.md) | [10.1](/filings/0001493152-24-031624.md) | [8.2](/filings/0001493152-24-044766.md) | [8.7](/filings/0001493152-26-016889.md) | [7.9](/filings/0001641172-25-009972.md) | [15.2](/filings/0001641172-25-023493.md) | [20.9](/filings/0001493152-25-021950.md) | [23.9](/filings/0001493152-26-039250.md) | [33.4](/filings/0001493152-26-024591.md) | [30.0](/filings/0001493152-26-039250.md) |
| Long-term debt | $m | [5.1](/filings/0001493152-23-041181.md) | [5.0](/filings/0001493152-24-009661.md) | [5.2](/filings/0001493152-24-018890.md) | [4.8](/filings/0001493152-24-031624.md) | [4.4](/filings/0001493152-24-044766.md) | [4.0](/filings/0001641172-25-000608.md) | [3.6](/filings/0001641172-25-009972.md) | [9.6](/filings/0001641172-25-023493.md) | [12.0](/filings/0001493152-25-021950.md) | [15.2](/filings/0001493152-26-024591.md) | not reported | [17.7](/filings/0001493152-26-039250.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [17.0](/filings/0001493152-26-024591.md) | not reported | [19.3](/filings/0001493152-26-039250.md) |
| Shareholders' equity | $m | [23.7](/filings/0001493152-23-041181.md) | [28.2](/filings/0001641172-25-000608.md) | [56.0](/filings/0001493152-24-018890.md) | [46.2](/filings/0001493152-24-031624.md) | [33.2](/filings/0001493152-24-044766.md) | [15.3](/filings/0001493152-26-016889.md) | [7.8](/filings/0001641172-25-009972.md) | [0.1](/filings/0001641172-25-023493.md) | [(6.4)](/filings/0001493152-25-021950.md) | [(15.3)](/filings/0001493152-26-039250.md) | [(23.8)](/filings/0001493152-26-024591.md) | [(20.7)](/filings/0001493152-26-039250.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.1 d](/filings/0001493152-24-044766.md) | [2.0 d](/filings/0001641172-25-000608.md) | [4.0](/filings/0001641172-25-009972.md) | [(4.1) d](/filings/0001641172-25-023493.md) | [(13.3) d](/filings/0001493152-25-021950.md) | [(7.9) d](/filings/0001493152-26-016889.md) | [(7.0)](/filings/0001493152-26-024591.md) | [(6.1) d](/filings/0001493152-26-039250.md) | [(4.6) d](/filings/0001493152-25-021950.md) | [(3.6) d](/filings/0001493152-26-016889.md) | [(4.6)](/filings/0001493152-26-024591.md) | [(2.6) d](/filings/0001493152-26-039250.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.4](/filings/0001493152-23-041181.md) | [14.5](/filings/0001493152-24-018890.md) | [15.1](/filings/0001493152-24-031624.md) | [14.5](/filings/0001493152-24-044766.md) | [18.7](/filings/0001641172-25-009972.md) | [19.4](/filings/0001641172-25-023493.md) | [19.7](/filings/0001493152-25-021950.md) | [20.1](/filings/0001493152-26-024591.md) | [19.9](/filings/0001493152-26-039250.md) | [19.8](/filings/0001493152-25-021950.md) | [23.7](/filings/0001493152-26-024591.md) | [25.9](/filings/0001493152-26-039250.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,908,423 at 2026-08-19, from the cover of the [10-Q filed 2026-08-19](/filings/0001493152-26-039250.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.